Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Interested in Gold Updates?
Receive the latest updates on the gold and silver markets.
...
Health Technology » Pharmaceuticals Other
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| VRX | Valeant Pharmaceuticals International, Inc. | 6.95% | 20.62 | 14.1% | $121.33m | |
| MDCO | Medicines Company | -0.66% | 52.01 | 20.3% | $106.13m | |
| GWPH | GW Pharmaceuticals PLC Sponsored ADR | -2.97% | 114.50 | 6.2% | $90.18m | |
| AMRN | Amarin Corporation Plc Sponsored ADR | 2.08% | 15.22 | 1.8% | $82.95m | |
| PRGO | Perrigo Co. Plc | 2.83% | 53.47 | 6.8% | $56.22m | |
| JAZZ | Jazz Pharmaceuticals Plc | 0.60% | 118.67 | 2.3% | $53.75m | |
| SAGE | SAGE Therapeutics, Inc. | 3.37% | 140.55 | 8.6% | $52.51m | |
| PCRX | Pacira Pharmaceuticals, Inc. | 2.50% | 37.69 | 10.5% | $44.41m | |
| UTHR | United Therapeutics Corporation | 1.41% | 81.89 | 14.3% | $40.50m | |
| CTLT | Catalent Inc | 2.01% | 48.63 | 2.4% | $35.04m | |
| HZNP | Horizon Pharma plc | 2.73% | 27.06 | 6.6% | $32.50m | |
| ICLR | ICON Plc | -0.20% | 142.18 | 4.1% | $32.03m | |
| ICPT | Intercept Pharmaceuticals, Inc. | 1.09% | 59.55 | 16.9% | $30.63m | |
| AERI | Aerie Pharmaceuticals, Inc. | 13.71% | 20.15 | 6.8% | $27.15m | |
| ENDP | Endo International Plc | 3.49% | 3.71 | 8.8% | $26.10m |
Company Profile
Ritter Pharmaceuticals, Inc. engages in the development of novel therapeutic products which modulate the human gut microbiome to treat digestive disorders and gastrointestinal diseases. It focuses on the development and commercialization of RP-G28. The company was founded by Andrew J. Ritter and Ira E. Ritter on March 29, 2004 and is headquartered in Los Angeles, CA.